According to several news organizations, Sandoz has issued a recall announcement regarding at least 10 lots of certain oral contraceptive drugs known as Introvale over incorrect order of the tablets present in these packages.
The official recall announcement issued by the Food and Drug Administration has revealed that these contraceptive packages could leave women at risk for an unintended pregnancy since placebo tablets were found within the blister packaging in the wrong order. The tablets, produced between January 2011 and May 2012 come with 84 peach-colored active tablets and seven white placebo tablets in 13 rows that should not be misplaced or put in an organized order since patients could mistaken the placebo tablets for the active tablets.
According to the firm, one consumer reported a problem with one of these packages, which prompted the recall.
All units listed under this recall announcement come with the following lot numbers printed on the packaging’s label: LF00479C, LF00478C, LF00552C, LF00551C, LF00688C, LF00687C, LF00764C, LF00763C, LF01261C and LF00765C. Adverse reactions or unintended pregnancies associated with this recalled lot have not yet been reported.
Consumers are advised to address any concern or questions to the company or the Food and Drug Administration. According to the U.S. Consumer Product Safety Commission, you should contact the company for a refund and your health care provider and ask about a non-hormonal alternative form of contraception.
Act fast and stay safe.